Kayexalate and Potassium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kayexalate (sodium polystyrene sulfonate) and Potassium (potassium). Common drug interactions include bone disorder among females and face oedema among males.

The phase IV clinical study analyzes what interactions people have when they take Kayexalate and Potassium. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Kayexalate?

Kayexalate has active ingredients of sodium polystyrene sulfonate. eHealthMe is studying from 5,004 Kayexalate users. Check the latest studies of Kayexalate.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,147 Potassium users. Check the latest studies of Potassium.



On Jul, 19, 2026

46 people who take Kayexalate and Potassium together, and have interactions are studied.

Kayexalate and Potassium drug interactions.

What are the common drug interactions of Kayexalate and Potassium, by gender? *:

female:

  1. Bone disorder
  2. Neuropathy peripheral (surface nerve damage)
  3. Osteomyelitis (infection of bone)
  4. Pain
  5. General physical health deterioration (weak health status)
  6. Hyperkalaemia (damage to or disease of the kidney)
  7. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
  8. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
  9. Diarrhoea
  10. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)

male:

  1. Face oedema (swelling of face)
  2. Hyperthermia (body temperature greatly above normal)
  3. Hyperuricaemia (level of uric acid in the blood that is abnormally high)
  4. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  5. Pancreatitis chronic (chronic inflammation of pancreas)
  6. Pulmonary arterial pressure increased
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Weight decreased
  9. Abscess neck (neck abscesses)
  10. Addison's disease (addison's disease, a hormonal disorder disease)

What are the common drug interactions of Kayexalate and Potassium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
  3. Gastritis haemorrhagic (inflammation of stomach with bleeding)

30-39:

  1. Hyperkalaemia (damage to or disease of the kidney)
  2. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
  3. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
  4. Abdominal pain
  5. Diarrhoea
  6. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  7. Epistaxis (bleed from the nose)
  8. Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
  9. General physical health deterioration (weak health status)
  10. Haemorrhoids (a swollen vein or group of veins in the region of the anus)

40-49:

  1. Hyperthermia (body temperature greatly above normal)
  2. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  3. Oedema peripheral (superficial swelling)
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Vitamin a deficiency
  6. Vitamin d deficiency
  7. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  8. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  9. Face oedema (swelling of face)

50-59:

  1. Abscess limb (limb infection)
  2. Bone disorder
  3. Neuropathy peripheral (surface nerve damage)
  4. Osteomyelitis (infection of bone)
  5. Pain
  6. Anaemia (lack of blood)
  7. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  8. Pancreatitis chronic (chronic inflammation of pancreas)
  9. Pulmonary arterial pressure increased
  10. Device related infection

60+:

  1. Urinary tract infection
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  4. Weight decreased
  5. Anaemia (lack of blood)
  6. Abscess neck (neck abscesses)
  7. Addison's disease (addison's disease, a hormonal disorder disease)
  8. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  9. Anaemia of chronic disease
  10. Aneurysm (enlargement of an artery caused by a weakening of the artery wall)

What are the existing conditions these people have? *

  1. Hyperkalemia (damage to or disease of the kidney): 32 people, 69.57%
  2. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 30 people, 65.22%
  3. Sepsis (a severe blood infection that can lead to organ failure and death): 25 people, 54.35%
  4. Depression: 24 people, 52.17%
  5. Insomnia (sleeplessness): 23 people, 50.00%
  6. Urinary Tract Infection: 16 people, 34.78%
  7. Osteoporosis (bones weak and more likely to break): 15 people, 32.61%
  8. Infection: 15 people, 32.61%
  9. Anaemia (lack of blood): 13 people, 28.26%
  10. Fever: 12 people, 26.09%

* Approximation only. Some reports may have incomplete information.

Do you take Kayexalate and Potassium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Kayexalate and Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Kayexalate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kayexalate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sodium polystyrene sulfonate and potassium (the active ingredients of Kayexalate and Potassium, respectively), and Kayexalate and Potassium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: